West Net Income vs Total Revenue Analysis

WST Stock

USD 360.43 7.75 2.10%

West Pharmaceutical financial indicator trend analysis is more than just analyzing West Pharmaceutical current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether West Pharmaceutical is a good investment. Please check the relationship between West Pharmaceutical Net Income and its Total Revenue accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Net Income vs Total Revenue

Net Income vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of West Pharmaceutical Net Income account and Total Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between West Pharmaceutical's Net Income and Total Revenue is 0.95. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Total Revenue in the same time period over historical financial statements of West Pharmaceutical Services, assuming nothing else is changed. The correlation between historical values of West Pharmaceutical's Net Income and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of West Pharmaceutical Services are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Net Income i.e., West Pharmaceutical's Net Income and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in West Pharmaceutical financial statement analysis. It represents the amount of money remaining after all of West Pharmaceutical Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Total Revenue

Total revenue comprises all receipts West Pharmaceutical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from West Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into West Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, West Pharmaceutical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 30.72 in 2024, whereas Enterprise Value is likely to drop slightly above 252.4 M in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	2.8B	2.9B	2.9B	3.1B
Depreciation And Amortization	126.1M	120.6M	137.3M	144.2M

Total Revenue Depreciation And Amortization

West Pharmaceutical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock
Total Assets		0.33	0.96	0.98	0.98	0.98	-0.87	0.97	0.97	0.98	0.51	0.97	0.98	0.67	0.12	0.99	0.91	-0.7	0.76	0.99	0.58	-0.35	0.98	0.94	0.54	0.54
Short Long Term Debt Total	0.33		0.41	0.31	0.17	0.29	0.09	0.13	0.2	0.4	0.23	0.21	0.23	0.49	0.93	0.27	0.24	0.03	0.65	0.23	-0.02	0.73	0.3	0.14	0.3	0.29
Other Current Liab	0.96	0.41		0.97	0.93	0.92	-0.83	0.9	0.94	0.94	0.62	0.94	0.96	0.69	0.21	0.96	0.86	-0.59	0.81	0.96	0.47	-0.25	0.98	0.87	0.53	0.53
Total Current Liabilities	0.98	0.31	0.97		0.96	0.96	-0.86	0.96	0.95	0.96	0.52	0.95	0.96	0.65	0.08	0.98	0.92	-0.72	0.76	0.97	0.64	-0.33	0.98	0.93	0.49	0.5
Total Stockholder Equity	0.98	0.17	0.93	0.96		0.97	-0.93	0.99	0.98	0.96	0.46	0.98	0.99	0.63	-0.04	0.99	0.91	-0.72	0.66	0.99	0.58	-0.5	0.97	0.96	0.54	0.55
Property Plant And Equipment Net	0.98	0.29	0.92	0.96	0.97		-0.83	0.97	0.93	0.99	0.35	0.93	0.96	0.71	0.1	0.98	0.91	-0.71	0.68	0.96	0.65	-0.35	0.96	0.93	0.58	0.58
Net Debt	-0.87	0.09	-0.83	-0.86	-0.93	-0.83		-0.93	-0.95	-0.79	-0.5	-0.95	-0.92	-0.44	0.32	-0.9	-0.79	0.69	-0.5	-0.93	-0.46	0.71	-0.87	-0.89	-0.47	-0.48
Retained Earnings	0.97	0.13	0.9	0.96	0.99	0.97	-0.93		0.97	0.94	0.41	0.97	0.97	0.56	-0.09	0.98	0.93	-0.81	0.66	0.98	0.64	-0.51	0.94	0.98	0.46	0.47
Cash	0.97	0.2	0.94	0.95	0.98	0.93	-0.95	0.97		0.92	0.55	1.0	0.98	0.57	-0.03	0.98	0.88	-0.71	0.71	0.99	0.5	-0.48	0.96	0.94	0.51	0.52
Non Current Assets Total	0.98	0.4	0.94	0.96	0.96	0.99	-0.79	0.94	0.92		0.4	0.92	0.95	0.76	0.22	0.97	0.9	-0.64	0.74	0.95	0.59	-0.25	0.97	0.9	0.59	0.6
Non Currrent Assets Other	0.51	0.23	0.62	0.52	0.46	0.35	-0.5	0.41	0.55	0.4		0.55	0.54	0.29	0.14	0.5	0.45	-0.14	0.55	0.54	0.03	-0.11	0.53	0.45	0.12	0.12
Cash And Short Term Investments	0.97	0.21	0.94	0.95	0.98	0.93	-0.95	0.97	1.0	0.92	0.55		0.98	0.56	-0.02	0.98	0.88	-0.71	0.71	0.99	0.49	-0.47	0.96	0.94	0.51	0.51
Net Receivables	0.98	0.23	0.96	0.96	0.99	0.96	-0.92	0.97	0.98	0.95	0.54	0.98		0.67	0.03	0.99	0.9	-0.66	0.71	0.99	0.52	-0.45	0.98	0.93	0.55	0.56
Common Stock Shares Outstanding	0.67	0.49	0.69	0.65	0.63	0.71	-0.44	0.56	0.57	0.76	0.29	0.56	0.67		0.43	0.67	0.57	-0.06	0.42	0.62	0.28	0.02	0.72	0.48	0.75	0.76
Non Current Liabilities Total	0.12	0.93	0.21	0.08	-0.04	0.1	0.32	-0.09	-0.03	0.22	0.14	-0.02	0.03	0.43		0.07	0.03	0.26	0.48	0.02	-0.21	0.84	0.1	-0.09	0.17	0.16
Inventory	0.99	0.27	0.96	0.98	0.99	0.98	-0.9	0.98	0.98	0.97	0.5	0.98	0.99	0.67	0.07		0.91	-0.7	0.72	0.99	0.57	-0.4	0.98	0.95	0.55	0.55
Other Current Assets	0.91	0.24	0.86	0.92	0.91	0.91	-0.79	0.93	0.88	0.9	0.45	0.88	0.9	0.57	0.03	0.91		-0.81	0.73	0.91	0.67	-0.34	0.87	0.95	0.32	0.33
Other Stockholder Equity	-0.7	0.03	-0.59	-0.72	-0.72	-0.71	0.69	-0.81	-0.71	-0.64	-0.14	-0.71	-0.66	-0.06	0.26	-0.7	-0.81		-0.57	-0.71	-0.73	0.45	-0.62	-0.85	0.02	0.01
Total Liab	0.76	0.65	0.81	0.76	0.66	0.68	-0.5	0.66	0.71	0.74	0.55	0.71	0.71	0.42	0.48	0.72	0.73	-0.57		0.73	0.31	0.13	0.72	0.67	0.15	0.16
Total Current Assets	0.99	0.23	0.96	0.97	0.99	0.96	-0.93	0.98	0.99	0.95	0.54	0.99	0.99	0.62	0.02	0.99	0.91	-0.71	0.73		0.53	-0.44	0.97	0.95	0.52	0.53
Short Term Debt	0.58	-0.02	0.47	0.64	0.58	0.65	-0.46	0.64	0.5	0.59	0.03	0.49	0.52	0.28	-0.21	0.57	0.67	-0.73	0.31	0.53		-0.29	0.55	0.68	0.12	0.13
Intangible Assets	-0.35	0.73	-0.25	-0.33	-0.5	-0.35	0.71	-0.51	-0.48	-0.25	-0.11	-0.47	-0.45	0.02	0.84	-0.4	-0.34	0.45	0.13	-0.44	-0.29		-0.37	-0.49	-0.16	-0.16
Accounts Payable	0.98	0.3	0.98	0.98	0.97	0.96	-0.87	0.94	0.96	0.97	0.53	0.96	0.98	0.72	0.1	0.98	0.87	-0.62	0.72	0.97	0.55	-0.37		0.9	0.59	0.6
Property Plant And Equipment Gross	0.94	0.14	0.87	0.93	0.96	0.93	-0.89	0.98	0.94	0.9	0.45	0.94	0.93	0.48	-0.09	0.95	0.95	-0.85	0.67	0.95	0.68	-0.49	0.9		0.37	0.38
Common Stock Total Equity	0.54	0.3	0.53	0.49	0.54	0.58	-0.47	0.46	0.51	0.59	0.12	0.51	0.55	0.75	0.17	0.55	0.32	0.02	0.15	0.52	0.12	-0.16	0.59	0.37		1.0
Common Stock	0.54	0.29	0.53	0.5	0.55	0.58	-0.48	0.47	0.52	0.6	0.12	0.51	0.56	0.76	0.16	0.55	0.33	0.01	0.16	0.53	0.13	-0.16	0.6	0.38	1.0

Click cells to compare fundamentals

West Pharmaceutical Account Relationship Matchups

West Pharmaceutical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.3B	2.8B	3.3B	3.6B	3.8B	4.0B
Short Long Term Debt Total	329.3M	325.7M	325.3M	317.9M	309M	227.6M
Other Current Liab	145.4M	226.9M	259.7M	228.1M	236M	247.8M
Total Current Liabilities	341.6M	503.4M	594.1M	519M	671.8M	705.4M
Total Stockholder Equity	1.6B	1.9B	2.3B	2.7B	2.9B	3.0B
Property Plant And Equipment Net	909.4M	1.0B	1.1B	1.3B	1.5B	1.6B
Net Debt	(109.8M)	(289.8M)	(437.3M)	(576.4M)	(544.9M)	(517.7M)
Retained Earnings	1.5B	1.8B	2.5B	3.0B	3.5B	3.7B
Cash	439.1M	615.5M	762.6M	894.3M	853.9M	896.6M
Non Current Assets Total	1.3B	1.4B	1.6B	1.7B	1.9B	2.0B
Non Currrent Assets Other	20.5M	29M	36.3M	55.9M	38.4M	33.8M
Cash And Short Term Investments	439.1M	615.5M	762.6M	894.3M	853.9M	896.6M
Net Receivables	319.3M	385.3M	489M	507.4M	512M	537.6M
Liabilities And Stockholders Equity	2.3B	2.8B	3.3B	3.6B	3.8B	4.0B
Non Current Liabilities Total	426.6M	435.9M	384.3M	412.9M	276.7M	307.8M
Inventory	235.7M	321.3M	378.4M	414.8M	434.7M	456.4M
Other Current Assets	64.6M	51.6M	112M	103M	135.8M	142.6M
Other Stockholder Equity	154.6M	99.6M	19.5M	(138.7M)	(517.4M)	(491.5M)
Total Liab	768.2M	939.3M	978.4M	931.9M	948.5M	995.9M
Total Current Assets	1.1B	1.4B	1.7B	1.9B	1.9B	2.0B
Short Term Debt	11.9M	12.4M	53.5M	18.2M	151.7M	159.3M
Intangible Assets	29.8M	30.5M	23M	18.4M	15.1M	14.3M
Accounts Payable	156.8M	213.1M	232.2M	215.4M	242.4M	254.5M
Property Plant And Equipment Gross	909.4M	1.0B	2.2B	2.4B	2.8B	3.0B
Accumulated Other Comprehensive Income	(149.6M)	(110.6M)	(159.6M)	(183M)	(143.8M)	(151.0M)
Other Liab	109.2M	117M	112.5M	113.2M	130.2M	107.9M
Other Assets	43M	52.3M	104.4M	104M	93.6M	50.4M
Long Term Debt	255M	252.9M	208.8M	206.7M	72.8M	69.2M
Good Will	107.8M	111.1M	109.9M	107.3M	108.5M	103.1M
Treasury Stock	(118.1M)	(167.7M)	(229.5M)	(370.9M)	(333.8M)	(317.1M)
Property Plant Equipment	839.3M	943.2M	1.1B	1.2B	1.3B	1.4B
Current Deferred Revenue	27.5M	51M	48.7M	57.3M	41.7M	38.2M
Net Tangible Assets	1.4B	1.7B	2.1B	2.6B	2.9B	3.1B
Retained Earnings Total Equity	1.5B	1.8B	2.5B	3.0B	3.4B	3.6B
Long Term Debt Total	255M	252.9M	208.8M	206.7M	186.0M	209.4M
Capital Surpluse	272.7M	267.3M	249M	232.2M	267.0M	223.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GM	General Motors
S	SentinelOne
MSFT	Microsoft

When determining whether West Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if West Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about West Pharmaceutical Services Stock. Highlighted below are key reports to facilitate an investment decision about West Pharmaceutical Services Stock:

How To Invest In West

Details

Is West Stock a good investment?

Details

What is West Pharmaceutical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for West Stock analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.

	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Money Managers Screen money managers from public funds and ETFs managed around the world
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing

Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.334

Dividend Share

0.77

Earnings Share

7.87

Revenue Per Share

39.701

Quarterly Revenue Growth

0.033

The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

West Net Income vs Total Revenue Analysis

Net Income vs Total Revenue

Net Income vs Total Revenue Correlation Analysis

Correlation Coefficient

Net Income

Total Revenue

West Pharmaceutical fundamental ratios Correlations

West Pharmaceutical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

West Pharmaceutical fundamental ratios Accounts

Also Currently Popular

Complementary Tools for West Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Inventory	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Net Receivables	+ 0.99	Total Stockholder Equity

Cash And Short Term Investments	- 0.95	Net Debt
Cash	- 0.95	Net Debt
Total Current Assets	- 0.93	Net Debt
Retained Earnings	- 0.93	Net Debt
Net Debt	- 0.93	Total Stockholder Equity
Net Receivables	- 0.92	Net Debt